Gap junctions coordinate electrical signals and facilitate metabolic synchronization between cells. In this study, the authors have developed a novel assay for the identification of gap junction blockers using fluorescence microscopy imaging-based high-content screening technology. In the assay, the communication between neighboring cells through gap junctions was measured by following the redistribution of a fluorescent marker. The movement of calcein dye from dye-loaded donor cells to dye-free acceptor cells through gap junctions overexpressed on cell surface membranes was monitored using automated fluorescence microscopy imaging in a high-throughput compatible format. The fluorescence imaging technology consisted of automated focusing, image acquisition, image processing, and data mining. The authors have successfully performed a high-throughput screening of a 486,000-compound program with this assay, and they were able to identify false positives without additional experiments. Selective and pharmacologically interesting compounds were identified for further optimization. (Journal of Biomolecular Screening 2003:489-499) 
INTRODUCTION

U
NDER THE GENOME-DRIVEN TARGET IDENTIFICATION PARADIGM, more and more challenging targets and regulatory pathways have been introduced to the high-throughput screening (HTS) departments of the pharmaceutical industry. These include neurite outgrowth, subcellular protein localization, cell-cell communication, receptor internalization or desensitization, and transporter assays. HTS amenable assays for these targets are difficult to develop using conventional screening technologies. The newly introduced high-content screening (HCS) systems [1] [2] [3] [4] [5] [6] [7] [8] [9] have the potential to play a pivotal role in enabling the development of HTS-compatible assays for these difficult targets. HCS refers to bioimaging assay technologies based on automated digital microscopy and image data mining. It provides temporal and spatial information about the behavior of the target at subcellular resolution. Most HCS platforms consist of automated image acquisition, processing, and data mining at medium to high throughput (3,000 to 10,000 data points per day).
HCS provides many advantages over conventional HTS technologies. HTS technologies normally are used to determine a single measurement per sample, generally of radioactivity, luminescence, or fluorescence. HTS assays can be either biochemical or cellular based. Either way, the data obtained contain minimal biological information. Therefore, potency information is the predominant basis for compound progression under the traditional drug discovery paradigm. HCS technologies normally refer to cel-lular or tissue-based assays from which multiple parameters are obtained. In addition to potency information for each sample, HCS also quantifies multiple effects of a compound, not only for its desired target but also for other cellular targets, thus facilitating the identification of the most interesting compounds and accelerating rational and predictive drug discovery. It can be used for both primary screening and follow-up assays.
Gap junctions are composed of a family of 21 or more proteins 10 that form intercellular channels that directly connect the cytoplasm of neighboring cells (Fig. 1) . These channels are different from orthodox ion channels in that they span 2 plasma membranes instead of 1. Junctional communications play important roles in brain physiology and cardiac function. The junctions are permeable to important secondary messengers, such as cAMP, cGMP, 1,4,5-trisphosphate (IP3) and Ca ++ , thus coordinating electrical signals and facilitating metabolic synchronization between cells. [10] [11] [12] [13] [14] [15] For example, it is believed that such cell-cell communication could lead to propagation of injury during ischemia, 16 and it has been hypothesized that compounds that specifically inhibit gap junction communication could be used to prevent the propagation of injury. Traditional assay methods for gap junction communication have included metabolic cooperation, 17 radioactive metabolite transfer, 18 electro-coupling, 19 dye transfer after microinjection 20 or scrape-loading, 21 fluorescence recovery after photo-bleaching, 22 evaluation of dye transfer by fluorescence-activated cell sorting, and manual quantification of dye transfer under fluorescent microscopy. 23 Although these assay methods are informative, all are labor intensive and are not compatible to HTS. The automated fluorescent microscopy-based ArrayScan II HCS system (software version 3.0) (Cellomics, Inc., Pittsburgh, PA) provided us with a unique opportunity to conduct a large-scale, medium-to highthroughput screening for identification of gap junction blockers. In this article, we report that using the basic tools provided by ArrayScan II, a robust quantitative measurement of gap junction communication based on calcein dye translocation was developed. This assay has been used to screen 486,000 compounds. The information-rich nature of the assay allowed us to eliminate false positives without additional tests. Chemical series with selectivity against different members of the gap junction target family were successfully identified.
MATERIALS AND METHODS
Cell lines
Rat glioma C6 cell lines stably expressing channels of different members of gap junction families were kind gifts from Professor David Paul of Harvard Medical School (Boston, MA), Professor Christian Naus of the University of Western Ontario (London, ON, Canada), and Professor Steffany Bennett of the University of Ottawa (Ottawa, ON, Canada). The parental rat glioma C6 cell line, cloned from a rat glial tumor induced by N-nitrosomethylurea, was obtained from the ATCC collection (Manassas, VA). The C6 cells were maintained in a log phase of growth at 37°C and 5% CO 2 in Dulbecco's Modified Eagle Medium with 10% FBS, 1× penicillinstreptomycin, and 200 µg/mL geneticin. Doubling time for the strain at the described growing condition is about 20 h.
Reagents
Calcein AM dye and Hoechst 33342 dye were purchased from Molecular Probes (Eugene, OR). 18-α-glycyrrhetinic acid (AGA) and Meclofenamic acid, nonselective gap junction blockers, were obtained from Sigma-Aldrich (St. Louis, MO). All cell culture reagents were purchased from Invitrogen (Carlsbad, CA). Remaining reagents were purchased from Sigma unless otherwise specified. The dye loading buffer contained 5 µM of calcein AM in Hanks Balanced Salt Solution (HBSS). The Stop & Wash buffer was composed of 75 µM of AGA and 1 µg/mL of Hoechst 33342 dye in HBSS. Primary screening was conducted using a mixture of 4 compounds diluted in 1× phosphate buffered saline (PBS), pH 7.5. Under the final assay conditions, the DMSO concentration was 0.4%, and the concentration of each compound was 10 µM.
Dye translocation assay
The assay was run in tissue-culture-treated 384-well Falcon plates (BD, Franklin Lakes, NJ). At least 1 day before the assay, the cells were divided into 1 T25 flask and 2 T175 flasks. At the beginning of assay, the cell culture was at about 95% confluence. The growth medium was aspirated from the T25 flask, the cells were washed twice with 5 mL of HBSS, and 5 mL of dye loading buffer was added. The cells were incubated at 37°C for 20 min to allow , then the cells were harvested with 0.25% Trypsin-EDTA solution. The donor cells (labeled) and the acceptor cells (unlabeled) were mixed at different ratios (1:10 to 1:80), then the cell mixture was diluted to different cell densities with the growth medium. The cell suspension was dispensed at 45 µL/well to the assay plates with the MultiDrop dispenser (LabSystem, Franklin, MA). The plates were centrifuged at 300 × g for 4 min and then incubated at 37°C and 5% CO 2 for 60 min. Under optimal conditions, the cells settled to a confluent monolayer in each well, which allowed gap junctions to form between neighboring cells. Test compounds, 750 µM of AGA (known inhibitor), or 4% DMSO in PBS solution were added to the assay plates at 5 µL/well and were allowed to incubate with the cells at 37°C and 5% CO 2 for various times. The growth medium was removed before dispensing 50 µL of Stop & Wash buffer into each well. The assay plates were then subjected to imaging. Living cell images must be acquired within 120 min after the addition of Stop & Wash buffer because the fluorescence intensity will have noticeably faded after about 240 min due to calcein dye leakage across the cellular membrane. Fixation of cells would not help because it damages the cell membranes and accelerates the leakage of the calcein dye.
Microscopy imaging and data analysis
The ArrayScan II system, which is an automated fluorescence microscopy imaging system, was used to study gap junction communication including reagent validation, assay development, screening, and follow-up analysis. To quantify the total number of cells occupied by the calcein dye that was diffused from donor cells to acceptor cells, the ArrayScan II system was applied to scan from well to well with dual wavelengths under a 10× objective lens (Zeiss Fluo Plan, NA = 0.6). The excitation and emission wavelengths for nucleus detection (Hoechst dye) were set centrally at 365 nm and 460 nm, respectively, with an exposure time of 0.1 s. The excitation and emission wavelengths for the cytoplasm channel (calcein dye) were 480 nm and 520 nm, respectively, with an exposure time of 0.36 s. For primary screening, 1 field per well was acquired with the autofocusing function on. For follow-up, multiple field measurements could be taken. Data analysis was conducted offline. A proprietary algorithm developed on the ArrayScan II was used to analyze the images. Nucleus number, cytoplasm area, cell perimeter, and fluorescence intensity from each cell were the key parameters used to quantify the gap junction communication.
RESULTS AND DISCUSSION
Image acquisition
Because ArrayScan is based on digital fluorescence microscopy imaging technology, its digital image resolution and imaging field size are system magnification dependent. At a given cell density per well, low magnification results in a larger field size, permitting more cells to be sampled; however, the resolution may not be sufficient to analyze individual cells. On the other hand, high magnification results in high resolution with a smaller field size, but fewer cells are sampled. Consequently, a greater number of images are needed to minimize variations in the sampling (Fig. 2) . These requirements of additional field numbers and tightened focusing standards reduce the throughput of HCS when higher magnification is applied. For example, under the same optical exposure condition, in our optimized gap junction communication assay, to view 1000 cells with 2 wavelengths, it will take 43 min to run through a plate using a magnification with the 10× objectives (about 1000 cells/field, 1 field/well), whereas it will take 94 min using a magnification with 20× objectives (about 250 cells/field, 4 fields/well). Combinations of different magnification levels and varied field numbers were tested. It was found that a magnification with the 10× objectives, and 1 field imaging per sample well, led to a high-quality primary screening with acceptable throughput. In confirmation and IC 50 experiments, multiple field numbers were taken per sample well to ensure the validity of the results.
The specificity of calcein dye translocation as the indicator of intercellular gap junction communication
Calcein AM is a cell-permeable dye widely used as a cell viability indicator. Only viable cells will convert the nonfluorescent AM ester of calcein to its fluorescent form in cytoplasm. Once formed, calcein is well retained in the cytosol and can pass into neighboring cells only through gap junctions. It is well documented in the literature that the calcein dye translocation between neighboring cells is gap junction dependent. 23 The concept was revalidated in our laboratory by comparing the kinetics of dye transfer for parental 
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rat C6 cells, which did not express gap junctions, with cells that overexpressed gap junction proteins. Under the selected dye loading condition, within 4 h of assay time, there was no significant transfer of calcein dye between rat C6 cells that did not express gap junction proteins, whereas the transfer between gap junction overexpression cells was substantial (data not shown).
Cell density and donor-to-acceptor ratio
Because the calcein dye transfer assay measures the cell-cell communication between neighboring cells connected by gap junctions, confluent yet monolayer cells within each testing well are essential to allow the diffusion of the calcein dye between neighboring cells. To minimize assay variation, the donor-to-acceptor ratio must be titrated carefully so that at the end of the assay, the number of cells occupied by the calcein dye diffused from donor cells to acceptor cells will be maximized. In addition, the time course of the dye-transfer assay must be linear or pseudo-linear to optimize the opportunity to identify gap junction blockers. Figure 3 demonstrates the influences of cell density and donor-to-acceptor ratio on the efficiency of junctional communication, based on the number of cells labeled by the calcein dye. Donor-to-acceptor ratios varied between 1:10 and 1:80 (data are not completely shown). It was observed that a 1:20 ratio offered the best signal-to-background ratio for the assay at appropriate cell densities. At a given donor-toacceptor ratio, due to the lack of direct contact between cells, the junctional communication was almost lacking when cell density was lower than 5,000 cells/well. When cell densities were between 5,000 and 12,000 cells/well, the communication began to occur. However, because there were not enough cells to cover the entire bottom of the well, cell "patches" formed randomly, resulting in high assay variation. At between 12,000 and 20,000 cells/well, a pseudo-monolayer of cells formed, which facilitated the optimal junctional communication. When cell density was greater than 20,000 cells/well, multiple layers of cells formed, interfering with the imaging analysis. Therefore, in the primary screening, a cell density of 18,000 cells/well was chosen, and the donor-to-acceptor ratio was set at 1:20.
Time dependency of dye transfer
Calcein appears to be unbound in the cytoplasm. Thus, calcein dye transfer between cells follows a pseudo-first-order reaction pathway between 0 and 210 min (Fig. 4) , reaching a limit after 210 min due to saturation of the cells in each well by the calcein dye. In the primary screening, the transfer of calcein dye between cells was permitted to occur for 120 min in the presence of compounds before cells were treated with Stop & Wash buffer.
Quantification of gap junction communication and key cellular parameters
It is important to notice that in the calcein dye transfer assay, the total fluorescence intensity from each testing well did not change on gap junction formation; however, the number of dye-labeled cells showed an increase when efficient gap junction communications were formed. In theory, therefore, a simple fluorescent spot counting should be sufficient to measure dye transfer and, consequently, the gap junction communication. In reality, however, this was an oversimplification. First of all, cell debris and foreign particles could be misidentified as cells, and cells often aggregated so that it was difficult to achieve accurate counting of cells. To solve this problem, we measured colocalization of cytoplasm dye, calcein, and the nuclear dye, Hoechst. This method effectively eliminated extraneous particles and increased the accuracy of cell counting, thus increasing our confidence in object identification. Second, we counted only cells that met preset values for cytoplasm area, nucleus size, cell perimeter, and fluorescence intensity (Fig. 5 , Table 1 ). Therefore, only cells that were labeled by both calcein and Hoechst dyes, while satisfying the above-mentioned criteria, were counted as labeled cells.
Concentration response curve for known gap junction blockers
Two known nonselective gap junction blockers, meclofenamic acid and AGA, were tested as positive controls in our assay to validate the analytical method. After cells were plated and allowed to attach for 60 min, various concentrations of the known blockers were added to the test wells. Cells were incubated with compounds at 37°C and 5% CO 2 for 120 min. After treating with Stop & Wash buffer, cell images were acquired, and the number of labeled cells with appropriate cytoplasm area, nucleus size, cell perimeter, and fluorescence intensity parameters was determined by the ArrayScan II system and subsequently compared with control wells in which no compounds had been added. As expected, the number of labeled cells detected decreased as the concentrations of blockers increased. For meclofenamic acid, the IC 50 value was 2.21 × 10 -4 M, and for AGA, the value was 3.22 × 10 -5 M (Fig. 6) . These values agreed well with the literature. 23 As the blocker concentration increased further, cytotoxicity became a dominant factor, evidenced by the decrease in total number of stained nuclei. 5A 5B 
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Primary screening for the identification of potential gap junction blockers
The fluorescent microscopy imaging-based gap junction assay was validated on the ArrayScan II system using 384-well plates. The final screening conditions were set as cell density: 18,000 cells/well, donor-to-acceptor ratio: 1:20, reaction time: 120 min, reaction temperature: 37°C. There were 2 factors limiting the throughput of the primary screening. First, the imaging acquisition speed was about 43 min per plate without online data analysis. Second, because living cells were used for image acquisition and calcein dye leaked passively through cell membranes, it was important to restrict the incubation time for all plates. Therefore, only twelve 384-well plates could be processed during a normal workday with workstation operation. To compensate for the time limitation and to accelerate the screening, primary screening was conducted using a mixture of 4 compounds per well. Raw image data (size: 392 Mb per 384-well plate) from each screening day were transferred to compact disks for archiving. Image analysis was conducted offline using the proprietary algorithm developed by Aventis based on the analysis software that came with ArrayScan II. In the primary screening, about 486,000 compounds (347 plates) were tested. The signal-to-background ratio was about 8 to 1, and coefficient of variation was about 15% (Fig. 7) . Plates with Z′ or Z factors 24 less than 0.4 were retested. All validated screening plates have a Z′ factor (for controls) greater than 0.4. To avoid missing clustered genuine hits, plates with a repeated Z factor (for test compounds) less than 0.4 were kept as well. Of 1515 compounds identified as positive through primary screening (0.3% hit rate), 103 compounds were confirmed (6.8% confirmation rate) by retesting (n = 3), and 53 compounds produced concentration response curves. Liquid handling errors, edge effect, and poor cell adhesion were the primary reasons for unconfirmed positives.
Elimination of false positives based on HCS information
Using HCS technology, false positives (from sources other than liquid handling errors, edge effect, and poor cell adhesion) can be easily identified at the primary screening stage. Unlike conventional cell-based assays for which additional assays are necessary to eliminate cytotoxic compounds, this HCS-based gap junction communication assay was able to automatically exclude cytotoxic compounds by monitoring nuclei numbers. Furthermore, interference from fluorescent compounds was minimized because the imaging was focused at the bottom of the well, thus limiting extraneous signal. Finally, in addition to quantifying the number of cells per field, other parameters such as nucleus size, cytoplasm area, cell perimeter, and fluorescence intensity were recorded for each cell within the imaging field. These parameters enabled us to elim-inate compounds that acted by distorting the morphology of the cells so that the physical contact between neighboring cells no longer existed. Such compounds are not of interest for the treatment of ischemia. After primary screening, we reexamined those compounds that reduced the number of labeled cells but failed to meet other criteria. As illustrated in Figure 8A -8C, these compounds were excluded as a gap junction blocker due to one of the following reasons. 1) It was cytotoxic.
2) It was a hydrophobic compound with strong fluorescence emission and cannot be removed by wash.
3) It altered the morphology of the cells. These observations further validated the algorithm developed on ArrayScan II to measure gap junction communication. Some false positives of gap junction blockers could not be eliminated automatically with the current software; however, they can be identified through visual inspection of the images. For example, certain types of compounds caused leaks in the cell membrane, resulting in release of calcein dye from donor cells to the assay solution, thus reducing the number of labeled cells (Fig. 8D) . In this situation, the fluorescence intensity of the donor cells decreased dramatically compared with the DMSO control.
Selectivity of the positives
Selectivity of the positives resulting from primary screening was tested against another member of the gap junction target family that has 33% homology in amino acid sequence to the primary target. Most chemical series did not demonstrate selectivity. Nevertheless, 2 scaffolds, each composed of more than 10 compounds, demonstrated divergent structure-activity-relationships (Fig. 9) .
CONCLUSION
By applying fluorescence microscopy imaging-based HCS technology, we have developed an HTS-amenable cell-imaging assay to quantify the degree of intercellular gap junctional communication. The assay was based on redistribution of intra- 
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cellular fluorescent dye from donor cells to acceptor cells, difficult to achieve utilizing conventional assay technologies. The automated fluorescence microscopy imaging-based assay provided us information about cells at subcellular levels, with satisfactory throughput (3,000 to 10,000 data points/day/instrument without automation). This information-rich assay allows us to have more reliable insights into effects of compounds, thus enabling us to eliminate compounds that acted through unrelated pathways during the primary screen and allowing us to quickly focus our efforts on truly interesting compounds. However, as in most cell-based assays, the current HCS technology could not dissect the protein(s) in the gap junction communication pathway targeted by the compounds. Isotopic labeling of the blockers may be used to identify the binding protein(s). In addition, to demonstrate that these gap junction blockers inhibit biological activity of gap junction rather than dye transportation, additional assays must be performed. Potential assays that suit this purpose include electrical conductance, epilepsy, and peripheral nervous system regeneration. To fully adapt the HCS technology for HTS, new systems with higher resolution, faster imaging and automation, more flexible configurations, and even more reliable data-mining algorithms will be required. Nevertheless, the application of HCS need not be limited exclusively to lead generation. The technology is highly applicable to the process of drug discovery, from functional genomics and target validation to lead generation and lead optimization. A B
